e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
COPD: human studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2011 Abstract: Suppression of antitumor immunity as a potential link between inflammation and cancer in COPD
S. Scrimini, J. Pons de Ves, A. Rios, A. Iglesias Coma, R. Cordoba, F. Polverino, J. Sauleda Roig (Palma de Mallorca, Spain; Cava dei Tirreni, Italy)
Source:
Annual Congress 2011 - COPD: human studies
Session:
COPD: human studies
Session type:
Thematic Poster Session
Number:
739
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Scrimini, J. Pons de Ves, A. Rios, A. Iglesias Coma, R. Cordoba, F. Polverino, J. Sauleda Roig (Palma de Mallorca, Spain; Cava dei Tirreni, Italy). LSC 2011 Abstract: Suppression of antitumor immunity as a potential link between inflammation and cancer in COPD. Eur Respir J 2011; 38: Suppl. 55, 739
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
LSC 2010 Abstract: Bacterial-induced protection against asthma through a novel multi-component immunoregulatory mechanism
Source: Annual Congress 2010 - Immune modulation of airways diseases
Year: 2010
Determinants of lung cancer evolution: immune escape and inflammation
Source: International Congress 2018 – Scientific Year in Review
Year: 2018
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
LSC 2010 Abstract: Deficient innate immune antiviral response to infection with rhinoviruses in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
LSC 2010 Abstract: Dynamics of inflammation and lung functioning in murine ozone model of COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
LSC 2011 Abstract: Inflammation and COPD: Protective effect of the recombinant anti-protease trappin-2 A62L, on lung epithelium
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Host-microbe interactions: implications for protective immunity in the lung
Source: Lung Science Conference 2015
Year: 2015
The role of interleukin-17 in asthma: a protective response?
Source: ERJ Open Res, 6 (2) 00364-2019; 10.1183/23120541.00364-2019
Year: 2020
Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LSC 2010 Abstract: Inhibition of innate host defense in airway epithelial cells by cigarette smoke in an
in vitro
infection model caused by suppression of NF-κB activation
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
LSC 2010 Abstract: Role of B-lymphocytes in a mouse model of chemical-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
LSC 2014 abstract - Targeting of microRNAs can restore innate anti-viral response in asthma
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
Modified sensitivity of alveolar cells to TRAIL-mediated apoptosis: a mechanism involved in emphysema pathogenesis with a potential impact on cancer therapy research
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept